BAYSHORE PHARMACEUTICALS FDA Record
- Latest inspection VAI · May 23, 2024
- No warning letters matched by name
BAYSHORE PHARMACEUTICALS has 2 FDA recalls, 1 inspection, 0 510(k) clearances and 0 compliance actions on record. No FDA warning letter addressed to "BAYSHORE PHARMACEUTICALS" is on file.
- Latest recall
- D-1544-2020 · Class II · Aug 19, 2020
- Latest inspection
- May 23, 2024 · VAI
Summary
| Records | Count | Last refreshed | Source as of | Status |
|---|---|---|---|---|
| Recalls | 2 | Nov 15, 2026 | File dated Nov 10, 2026 | Current |
| 510(k) clearances | 0 | Nov 15, 2026 | File dated Nov 9, 2026 | Current |
| Inspections | 1 | Nov 17, 2026 | Newest record Nov 9, 2026 | Current |
| Compliance actions | 0 | Nov 2, 2026 | Newest record Oct 29, 2026 | Current |
FDA record by year
BAYSHORE PHARMACEUTICALS: FDA inspections per year
| Year | Inspections | OAI | Warning letters | Recall records | Class I |
|---|---|---|---|---|---|
| 2026 | 0 | 0 | 0 | 0 | 0 |
| 2025 | 0 | 0 | 0 | 0 | 0 |
| 2024 | 1 | 0 | 0 | 0 | 0 |
| 2023 | 0 | 0 | 0 | 0 | 0 |
| 2022 | 0 | 0 | 0 | 0 | 0 |
| 2021 | 0 | 0 | 0 | 0 | 0 |
| 2020 | 0 | 0 | 0 | 2 | 0 |
| 2019 | 0 | 0 | 0 | 0 | 0 |
| 2018 | 0 | 0 | 0 | 0 | 0 |
| 2017 | 0 | 0 | 0 | 0 | 0 |
Reviewing BAYSHORE PHARMACEUTICALS as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check BAYSHORE PHARMACEUTICALS yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Recent recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-1544-2020 | Class II | Metformin Hydrochloride Extended-Release Tablets USP, 750 mg 100 Tablets Rx Only Manufactured by… | Aug 19, 2020 |
| D-1543-2020 | Class II | Metformin Hydrochloride Extended-Release Tablets USP, 500 mg 1000 Tablets Rx Only Manufactured by… | Aug 19, 2020 |
Recent FDA inspections
| Date | Site | Product | Classification | FEI |
|---|---|---|---|---|
| May 23, 2024 | Tampa, FL | Food/Cosmetics | Voluntary Action Indicated (VAI) | 3009313683 |
- NAI
- No objectionable conditions or practices were found during the inspection.
- VAI
- Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
- OAI
- Regulatory and/or administrative actions are recommended.
FDA-inspected facilities
| Facility | Location | Inspections | Latest |
|---|---|---|---|
| FEI 3009313683 | Tampa, FL | 1 | May 23, 2024 |
BAYSHORE PHARMACEUTICALS and the FDA: common questions
Has BAYSHORE PHARMACEUTICALS received an FDA warning letter?
No FDA warning letter addressed to the name "BAYSHORE PHARMACEUTICALS" is on file. This answer covers that name only: letters addressed to a related company name or to one of its sites are listed on that name's or site's own page.
Has BAYSHORE PHARMACEUTICALS received an FDA Form 483?
FDA has not published a Form 483 for "BAYSHORE PHARMACEUTICALS" in its reading room. FDA publishes some Form 483s, not all of them.
When did the FDA last inspect BAYSHORE PHARMACEUTICALS?
The most recent FDA inspection on file ended May 23, 2024 at Tampa, FL and was classified VAI. FDA has 1 inspection of BAYSHORE PHARMACEUTICALS on file.
Has BAYSHORE PHARMACEUTICALS had an FDA recall?
Yes. BAYSHORE PHARMACEUTICALS has 2 FDA recalls on record. The most recent started Aug 19, 2020.
Need more than this page shows? Ask about BAYSHORE PHARMACEUTICALS in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.